Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Caroline Palomeque is an analyst at Maxim Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/09/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
08/14/2024 | DARE | Buy Now | Dare Bioscience | $2.90 | — | Caroline Palomeque60% | — | Downgrade | Buy → Hold | Get Alert |
09/07/2023 | HRMY | Buy Now | Harmony Biosciences | $26.57 | 122.05% | Caroline Palomeque60% | → $59 | Initiates | → Buy | Get Alert |
09/07/2023 | KRYS | Buy Now | Krystal Biotech | $156.60 | -1.66% | Caroline Palomeque60% | → $154 | Initiates | → Buy | Get Alert |
03/27/2023 | HALO | Buy Now | Halozyme Therapeutics | $56.35 | 2.93% | Caroline Palomeque60% | → $58 | Reinstates | → Buy | Get Alert |
03/16/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Caroline Palomeque60% | → $22 | Reinstates | → Hold | Get Alert |
08/30/2022 | ASND | Buy Now | Ascendis Pharma | $137.19 | 21% | Caroline Palomeque60% | → $166 | Assumes | → Buy | Get Alert |
06/23/2022 | DNLI | Buy Now | Denali Therapeutics | $11.02 | 253.9% | Caroline Palomeque60% | → $39 | Initiates | → Buy | Get Alert |
06/23/2022 | RGNX | Buy Now | Regenxbio | $5.28 | 1054.84% | Caroline Palomeque60% | → $61 | Initiates | → Buy | Get Alert |
06/23/2022 | AVXL | Buy Now | Anavex Life Sciences | $7.45 | 436.91% | Caroline Palomeque60% | → $40 | Initiates | → Buy | Get Alert |
04/08/2022 | AGRX | Buy Now | Agile Therapeutics | $1.51 | — | Caroline Palomeque60% | — | Downgrade | Buy → Hold | Get Alert |
11/29/2018 | AGRX | Buy Now | Agile Therapeutics | $1.51 | 98.68% | Caroline Palomeque60% | → $6000 | Initiates | → Buy | Get Alert |
08/17/2018 | DARE | Buy Now | Dare Bioscience | $2.90 | 3.45% | Caroline Palomeque60% | → $36 | Initiates | → Buy | Get Alert |